HELP: Helus Pharma Inc.
Performance
HELP +56.69%
Watchlist
Select an item
Summary
HELP at a glance
HELP returned +56.69% over the past year and -33.70% a year over five years. Its worst drop in that year was -55.57%, smaller than 16% of stocks on Redstone, and its Sharpe ratio of 0.93 beats 72% of stocks on Redstone. It pays no dividends.
Current Drawdown
-33.17%
Rolling Volatility
80.90%
Actions
Metrics
Risk Indicators
Alpha60.09%
Beta2.04x
Sharpe0.93
Sortino1.33
Omega1.18
Calmar1.02
Martin2.84
Profile
About HELP
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways.
- Sector
- Health Care
- Market cap
- $685M
- Listed
- Nov 2020
- Employees
- 50
- Website
- helus.com
Comparisons